IDH1 mutant negative ganglioglioma progression to gliosarcoma

Gangliogliomas comprise of less than 1% of all primary brain tumours. Malignant transformation is rare. Correspondingly, secondary gliosarcomas, especially in the absence of previous irradiation exposure is too, exceedingly rare. Recent evidence supports the use of mutant IDH1 testing in suspected a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Liming Qiu, Yee Lin Tang, Nicolas K.K. King, Khoon Leong Chuah, Siang Hui Lai, Keith H.C. Lim, Wai Hoe Ng, Sharon YY Low
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2017-09-01
Colección:Interdisciplinary Neurosurgery
Acceso en línea:http://www.sciencedirect.com/science/article/pii/S2214751916300809
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares